Literature DB >> 531055

The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).

J M Walshe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 531055

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  5 in total

Review 1.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

Review 2.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

3.  Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.

Authors:  Ji-Ming Yin; Li-Bo Sun; Jia-Sheng Zheng; Xin-Xin Wang; De-Xi Chen; Ning Li
Journal:  Inflamm Res       Date:  2016-09-09       Impact factor: 4.575

4.  Quantification of ATP7B Protein in Dried Blood Spots by Peptide Immuno-SRM as a Potential Screen for Wilson's Disease.

Authors:  Sunhee Jung; Jeffrey R Whiteaker; Lei Zhao; Han-Wook Yoo; Amanda G Paulovich; Si Houn Hahn
Journal:  J Proteome Res       Date:  2016-12-09       Impact factor: 4.466

5.  Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case.

Authors:  R G Watson
Journal:  Ulster Med J       Date:  1983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.